Obesity and Nutrition
Obesity and Nutrition
![Foto de Obesity and Nutrition](/img/grupo.png)
![Foto de University of Florence](/img/noimage_org.png)
University of Florence
Florencia, ItaliaPublications in collaboration with researchers from University of Florence (92)
2024
-
Hyponatremia, hypernatremia and impairment of functional, psychological and sexual domains
Journal of Endocrinological Investigation, Vol. 47, Núm. 4, pp. 1005-1014
2023
-
Diminishing benefits of urban living for children and adolescents’ growth and development
Nature, Vol. 615, Núm. 7954, pp. 874-883
-
Does testosterone influence the association between sleep and frailty in men: results from the European Male Aging Study
BMC Geriatrics, Vol. 23, Núm. 1
-
Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c
Nature Medicine, Vol. 29, Núm. 11, pp. 2885-2901
-
Number of CAG repeats and mortality in middle aged and older men
Clinical Endocrinology, Vol. 99, Núm. 6, pp. 559-565
-
Sarcopenia-defining parameters, but not sarcopenia, are associated with cognitive domains in middle-aged and older European men
Journal of Cachexia, Sarcopenia and Muscle, Vol. 14, Núm. 3, pp. 1520-1532
2022
-
Aging Men With Insufficient Vitamin D Have a Higher Mortality Risk: No Added Value of its Free Fractions or Active Form
The Journal of clinical endocrinology and metabolism, Vol. 107, Núm. 3, pp. e1212-e1220
-
Association of age, hormonal, and lifestyle factors with the Leydig cell biomarker INSL3 in aging men from the European Male Aging Study cohort
Andrology, Vol. 10, Núm. 7, pp. 1328-1338
-
Erectile dysfunction predicts mortality in middle-aged and older men independent of their sex steroid status
Age and ageing, Vol. 51, Núm. 4
-
Reproductive hormone levels, androgen receptor CAG repeat length and their longitudinal relationships with decline in cognitive subdomains in men: The European Male Ageing Study.
Physiology and Behavior, Vol. 252
-
The Leydig cell biomarker INSL3 as a predictor of age-related morbidity: Findings from the EMAS cohort
Frontiers in Endocrinology, Vol. 13
2021
-
Inflammatory markers are associated with quality of life, physical activity, and gait speed but not sarcopenia in aged men (40–79 years)
Journal of Cachexia, Sarcopenia and Muscle, Vol. 12, Núm. 6, pp. 1818-1831
-
Self-Reported Shorter Than Desired Ejaculation Latency and Related Distress—Prevalence and Clinical Correlates: Results From the European Male Ageing Study
Journal of Sexual Medicine, Vol. 18, Núm. 5, pp. 908-919
2020
-
Repositioning of the global epicentre of non-optimal cholesterol
Nature, Vol. 582, Núm. 7810, pp. 73-77
2019
2018
-
Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: A pooled analysis of 1018 population-based measurement studies with 88.6 million participants
International Journal of Epidemiology, Vol. 47, Núm. 3, pp. 872-883i
-
Elevated luteinizing hormone despite normal testosterone levels in older men—natural history, risk factors and clinical features
Clinical Endocrinology, Vol. 88, Núm. 3, pp. 479-490
-
Reproductive hormone levels predict changes in frailty status in community-dwelling older men: European male ageing study prospective data
Journal of Clinical Endocrinology and Metabolism, Vol. 103, Núm. 2, pp. 701-709
-
Symptomatic androgen deficiency develops only when both total and free testosterone decline in obese men who may have incident biochemical secondary hypogonadism: Prospective results from the EMAS
Clinical Endocrinology, Vol. 89, Núm. 4, pp. 459-469
2017
-
Changes in prevalence of obesity and high waist circumference over four years across European regions: the European male ageing study (EMAS)
Endocrine, Vol. 55, Núm. 2, pp. 456-469